Skip to main content
Neuro-Oncology Practice logoLink to Neuro-Oncology Practice
. 2024 Jun 20;11(6):703–712. doi: 10.1093/nop/npae055

Cerebrospinal fluid diversion prior to posterior fossa tumor resection in adults: A systematic review

Amisha Vastani 1,#, Asfand Baig Mirza 2,#,, Fizza Ali 3, Allayna Iqbal 4, Chaitanya Sharma 5, Abbas Khizar Khoja 6, Babar Vaqas 7, José Pedro Lavrador 8, Jonathan Pollock 9
PMCID: PMC11567752  PMID: 39554780

Abstract

Background

Posterior fossa tumors (PFTs) comprise 15%–20% of adult brain tumors, with the reported frequency of hydrocephalus (HCP) ranging between 3.7% and 58%. Most HCP resolves after resection of PFTs, but studies report persistent or new-onset HCP occurring in between 2% and 7% of cases. Preoperative cerebrospinal fluid (CSF) diversion with a ventriculoperitoneal shunt (VPS), external ventricular drain (EVD), or endoscopic third ventriculostomy (ETV) has been shown to improve outcomes. Evidence regarding the efficacy of these techniques is limited.

Methods

A systematic literature search was performed in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Data points were extracted from individual patient cohort data. A failure rate was determined by the number of patients requiring further postoperative CSF diversion.

Results

In total, 8863 records were identified. Thirteen studies consisting of 17 patient cohorts met our inclusion criteria. Across all individual cohort studies, 2976 patients underwent surgical resection of a PFT in whom the frequency of hydrocephalus at presentation was 22.98% (1.92%–100%), and persistent hydrocephalus following preoperative CSF diversion was 13.63% (0%–18%). Of the 684 hydrocephalic patients, 83.63% underwent CSF diversion in the form of ETV, EVD, or VPS. Between years 1992 and 2020, 1986 and 2021, and 1981and 2013, the pre-resection ETV, EVD, and VPS failure rates were 14.66% (17/116), 16.26% (60/369), and 0% (0/87), respectively.

Conclusions

This systematic review highlights that VPS has a better failure rate profile in minimizing postoperative hydrocephalus in adult patients with PFTs.

Keywords: CSF diversion, EVD, hydrocephalus, posterior fossa tumor, VPS


Posterior fossa tumors (PFTs) comprise 15%–20% of adult brain tumors.1 Tumors arising within the limited volume of the posterior fossa can produce a mass effect with compression of the cerebellum, brainstem, and/or fourth ventricle.2 The frequency of hydrocephalus (HCP) in adults with PFTs ranges between 3.7% and 58%.3–5

Although the majority of HCP resolves after resection of PFTs, studies have reported a rate of persistent and new-onset HCP after PFT surgery of between 2% and 7%,6–8 with postoperative HCP adversely affecting prognosis, increasing the length of stay and cost of hospitalization.9

When PFT resection does not resolve the HCP, postoperative cerebrospinal fluid (CSF) diversion has been implemented to manage postoperative HCP10 with placement of a ventriculoperitoneal shunt (VPS), an external ventricular drain (EVD), or endoscopic third ventriculostomy (ETV).6,11 Advantages of preoperative CSF diversion include symptomatic improvement, relaxation of the cerebellum during surgery (thereby minimizing iatrogenic injury), decreased incidence of CSF leak post-PFT resection, a reduction in inpatient mortality, and a reduced requirement for postoperative CSF diversion.12–15

Determining the best preoperative CSF diversion method is not straightforward. ETV is considered if the obstructive HCP is expected to be reversible following PFT resection, and VPS is selected if the HCP is unlikely to be reversible.16 Although EVD placement resolves CSF obstruction in most cases, particularly when gross total resection of the PFT is achieved, 1.2%–6.9% of patients will still require permanent CSF diversion post-tumor resection.17

A selective approach to preoperative CSF diversion is mandated by the risks including neurological injury,18–20 intracranial infection, hemorrhage, VPS malfunction, and postoperative ETV obstruction.9 These risks are justified in patients with acute symptomatic hydrocephalus where re-establishing CSF flow is a priority.

It is helpful to define the population at risk of persistent hydrocephalus21 and identify which CSF diversion method is preferable in reducing post-PFT resection complications. Many studies have examined predictive factors for postoperative hydrocephalus,22–25 particularly in pediatric patients22 with limited studies addressing the adult cohort.8,25 We, therefore, performed a comprehensive systematic review, to retrospectively analyze CSF diversion treatment modalities utilized in adult patients prior to PFT resection, and determine which method is most successful.

Methods

We performed this systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Figure 1), and the study protocol was published on PROSPERO (CRD42022357254). A systematic search of 6 databases (PubMed, APA PsychInfo, Embase, Medline, Global Health, and Cochrane Reviews) was performed for articles published before September 23, 2022. The following keywords were searched in all databases: “CSF diversion,” “posterior fossa tumour,” “hydrocephalus,” and variations of the intervention names (EVD, ETV, and VPS)—see Supplementary Appendix A for the search strategy.

Figure 1.

Figure 1.

PRISMA flow diagram of the study selection process for this review.

Three authors (A.B.M., F.A., and A.I.) independently and blindly screened the titles and abstracts for relevance. All references were further screened, and relevant literature was harvested that was not identified in the initial screen. We sought studies that met the inclusion and exclusion criteria as per our selection criteria defined in our Patient, Intervention, Comparison and Outcomes (PICO) model (Table 1). Any conflicts of inclusion or queries were resolved by consensus discussion and agreement between senior authors (A.B.M., J.P.L., B.V., and J.R.P.).

Table 1.

The Selection Criteria for Screening Based on the Patient, Intervention, Comparison, and Outcomes (PICO) Model

PICO Inclusion Exclusion
i. Population or participants and conditions of interest
  • Aged 16 years or over.

  • Preoperative patients

  • With posterior fossa neoplasm

  • With or without hydrocephalus on preoperative imaging

  • Below 16 years of age

  • Nonoperative management

  • Brainstem neoplasm

ii. Interventions or exposures
  • Surgical management of posterior fossa lesion via any of the following 3 modalities: external ventricular drain (EVD), ventriculoperitoneal shunt, or endoscopic ventriculostomy (ETV), placed prior to resection of the posterior fossa tumor only

  • Hydrocephalus not associated with tumor

  • Previously operated cranial surgery

  • Previous CSF diversion

  • Postoperative CSF drainage as initial CSF diversion treatment

iii. Comparisons or control groups
  • Adult patients with or without hydrocephalus who have had CSF diversion performed with any of the three modalities listed above

  • Below 16 years of age

  • Alternative CSF diversion modality used

iv. Outcomes of interest
  • Requirement of further postoperative CSF diversion

v. Setting
  • Hospital admission to a secondary or tertiary center

vi. Study designs
  • Retrospective cohort studies (observational studies)

  • Not in English

  • Full text unavailable

  • Not original research

  • Case reports

Data extraction was performed independently by (A.B.M., F.A., A.I., and A.V.). Publication information (author, year published, country of origin); overview of study design (aims, intervention studied, follow-up period); patient characteristics (sex ratio, mean age, presence of pre- or postoperative hydrocephalus); nature of intervention (type of intervention, failure and success rate, conversion rate, surgical outcome); tumor information (size, location and type of tumor, extent of tumor resection). Preoperative hydrocephalus was determined by both clinical and radiological findings. Preoperative clinical hydrocephalus was determined with symptoms including but not limited to headache, nausea, vomiting, and papilledema. Preoperative radiological hydrocephalus was determined with the use of CT with/without MRI imaging assessing the Evan Index >0.3 and compression of the aqueduct of Sylvius. Papers were graded and assessed qualitatively using the Newcastle–Ottawa quality assessment scale for cohort studies as shown in Supplementary Appendix B.

Results

A comprehensive literature search was performed from the inception of each respective database to September 23, 2022, as displayed in Figure 1. Our search returned 8863 records, of which 13 studies consisting of 17 patient cohorts met our inclusion criteria. Across all cohort studies, 2976 patients underwent surgical resection of a PFT, and 684 patients had preoperative hydrocephalus, of whom 83.63% (572/684) underwent pre-/intraoperative CSF diversion in the form of ETV, EVD, or VPS. For all patients included in this study, CSF diversion was required due to preoperative hydrocephalus or to prophylactically reduce the likelihood of postoperative hydrocephalus. Most studies confirmed preoperative hydrocephalus radiologically (12/13 studies), with a portion of these also recording symptomatic diagnoses (9/13).

Endoscopic Third Ventriculostomy

The use of ETV for preoperative CSF diversion in adult PFTs was found in 5 patient cohorts5,25–29 between the years 1992 and 2020, with a total of 190 surgically managed adult PFT cases as shown in Table 2. An average age of 42.62 years (28–55 years), of which approximately 51.77% (73/141) are female.

Table 2.

Systematic Review: Cerebrospinal Fluid Diversion Using Endoscopic Third Ventriculostomy Outcomes in Adults Prior to Posterior Fossa Tumor Resection

References Total adult PFT cases (N) Preoperative HCP cases (N) CSF diversion cases (N) Age (years) Male (female) (N) Follow-up Postoperative HCP (N) CSF drainage failure (N) Details of failure Failure rate (%) Postoperative complications (N) Anatomical location of tumor Histopathology of tumor Extent of tumor resection (N or %)
Ardakani et al. (2014)27 8 8 8 47.5 5 (3) 6 months 3 VPS (2), Death (1) Meningitis requiring VPS (1), Fulminate meningitis leading to death (1), HC requiring VPS (1), All 3 within first-week postop 37.50% 0 CPA with mass effect on brainstem (VS) VS (8) NS
Grunert et al. (2003)26 49 49 49 35 NS NS 9 VPS (7) NS 14.29% 0 “Compressing aqueduct” NS NS
Mangubat et al. (2009)29 43 8 8 46.8 NS NS 4 VPS (4) 0 50% NS Posterior fossa (NS) Unable to determine from data NS
Marx et al. (2018)5 74 35 35 55 16 (19) Mean follow-up of 67.2 months (2–204 months) 3 ETV re-do (1), EVD (2) 1 additional wound revision due to CSF fistula 8.57% CSF collection (conservative) (1), CSF fistula—wound revision (1), re-bleed (1), cerebellar infarct (1), post-resection edema with herniation (1), ventriculitis (1), EDH (1) NS Metastasis (10), meningioma (12), VS (3), hemangioblastoma (1), ependymoma (2), pilocytic astrocytoma (3), dermoid (3), sarcoma (1) GTR (23), STR (12)
Salah et al. (2022)28 16 16 16 28.31 10 (6) Median was 9 months (3–13 months) 1 Converted to EVD followed by VPS (1) 18M cerebellar astrocytoma, CSF infection 5D post-tumor resection. EVD and Abx, followed by VPS 6.25% 0 NS Cerebellar astrocytoma (5), ependymoma (5), medulloblastoma (4), diffuse pontine glioma (2) NS

Abbreviations: Abx, antibiotics; CPA, cerebellopontine angle; CSF, cerebrospinal fluid; EDH, extradural hemorrhage; ETV, endoscopic third ventriculostomy; EVD, external ventricular drain; GTR, gross total resection; HCP, hydrocephalus; NS, not stated; PFT, posterior fossa tumor; STR, subtotal resection; VPS, ventriculoperitoneal shunt; VS, vestibular schwannoma.

In all, 61.05% (116/190) of adult PFTs presented with preoperative hydrocephalus. One hundred percent were managed initially with a preoperative/intraoperative ETV, of which 17.24% (20/116) were found to have postoperative hydrocephalus on CT or MR imaging, with a resultant preoperative ETV failure rate of 14.66% (17/116). Failed ETVs were managed with VPS insertion in 82.35% (14/17), a right-sided EVD in 11.76% (2/17), and a revision ETV in 5.88% (1/17) of cases.

Marx et al.5 reported complications (7 in total) including 2 hemorrhages, 1 CSF collection managed conservatively, 1 CSF fistula managed with wound revision, 1 cerebellar infarct, 1 post-resection edema with herniation, and 1 ventriculitis. Three-fifths of studies26–28 reported no complications, with 1 study not stating whether or not they had complications.29

External Ventricular Drain

EVDs were used for preoperative CSF diversion in 7 patient cohorts5,8,9,30–33 between years 1986 and 2021, with a total of 2168 surgically managed adult PFT cases as shown in Table 3. An average age of 52.84 years (19–83 years),5,8,9,33 of which approximately 58.53% (957/1635) patients were female. Three patient cohorts did not state the average age and sex of patients,30–32 yet were included as the age of the youngest included patient was 16 years.

Table 3.

Systematic Review: Cerebrospinal Fluid Diversion Using External Ventricular Drain Outcomes in Adults Prior to Posterior Fossa Tumor

Reference Total adult PFT cases (N) Preoperative HCP cases (N) CSF diversion cases (N) Age (years) Male (female) (N) Follow-up Postoperative HCP (N) CSF drainage failure (N) Details of failure Failure rate (%) Postoperative complications (N) Anatomical location Histopathology of tumor Extent of tumor resection (N or %)
Atlas et al. (1996)32 104 3 3 NS NS 12–48 months NS 0 0 0% CVA (1) CPA VS 50% GTR
Marx et al. (2018)5 74 2 2 NS NS NS 0 0 0 0% 0 NS NS NS
Pirouzmand et al. (2001)30 284 39 35 54.31 18 (17) Mean of 26.4 months (6–120 months) 5 VPS (5) NS 14.28% Pseudo-meningocele, CN 6/9/10 palsies CPA VS (27), meningioma (5), NF2 (2), hemangioma (1) NS
Prabhuraj et al. (2017)31 145 75 19 50.42 NS 6 months Yes, details NS VPS (4) NS 21.05% NS CPA VS (19) NS
Saad et al. (2021)33 617 74 117 51 50 (67) NS 37 VPS (37) NS 31.62% Postop IVH, need for re-op NS NS GTR 62%
Won et al. (2020)8 262 100 186 NS NS Mean of 19.2 months 12 VPS (12) 3/12 VPS revision (2 infection, 1 dysfunction) 6.45% 0 NS Metastasis (77, 29.5%), meningioma (58, 22%), vestibular schwannoma (46, 17.8%). 5 NOT STATED 175 GTR, 85 STR, 2 biopsy
Zhang et al. (2022)9 682 136 7 39.14 3 (4) 3–72 months 2 VPS (2) NS 28.57% NS NS VS (1), astrocytoma (3), choroid plexus papilloma (1), ganglioglioma (1), medulloblastoma (1) GTR (4), STR (3)

Abbreviations: CN, cranial nerve; CPA, cerebellopontine angle; CSF, cerebrospinal fluid; CVA, cerebral vascular accident; GTR, gross total resection; HCP, hydrocephalus; IVH, intraventricular hemorrhage; NF2, neurofibromatosis type 2; NS, not stated; PFT, posterior fossa tumor; STR, subtotal resection; VPS, ventriculoperitoneal shunt; VS, vestibular schwannoma.

In all, 19.79% (429/2168) of adult PFTs presented with preoperative hydrocephalus, of which 86.01% (369/429) were managed initially with a preoperative/intraoperative EVD, of which 16.26% (60/369) were found to have postoperative hydrocephalus on CT or MR imaging, which required a VPS to be inserted.

Five patient cohorts did not report complication details of patient cases requiring further CSF diversion, after undergoing preoperative EVD and tumor resection.8,9,30,31,33 One patient cohort,32 reporting a failure rate of 31.62% (37/117), reported an additional case which developed a postoperative intraventricular hemorrhage and required further surgical intervention; however, the patient did not report further CSF diversion management.

Ventriculoperitoneal Shunt

The use of ventriculoperitoneal shunting for preoperative CSF diversion in adult PFTs was found in 5 patient cohorts30–32,34,35 between years 1981 and 2013, with a total of 618 surgically managed adult PFT cases as shown in Table 4. Sheikh and Kanaan35 reported an average age of 26.70 years (17–39 years), of which 47.06% (290/618) were female. The remaining 4 patient cohorts did not state the average age range or male:female ratio.30–32,34

Table 4.

Systematic Review: Cerebrospinal Fluid Diversion Using Ventriculoperitoneal Shunt Outcomes in Adults Prior to Posterior Fossa Tumor Resection

Reference Total adult PFT cases (N) Preoperative HCP cases (N) CSF diversion cases (N) Age (years) Male (female) (N) Follow-up Postoperative HCP (N) CSF drainage failure (N) Details of failure Failure rate (%) Postoperative complications (N) Anatomical location Histopathology of tumor Extent of tumor resection (N or %)
Atlas et al. (1996)32 104 2 2 54 NS 12–48 months NS 0 0 0% 0 CPA VS 33% GTR
Fukuda et al. (2007)34 68 16 4 55.25 1 (3) 50 months 0 0 0 0% NS CPA VS NS
Pirouzmand et al. (2001)30 284 39 4 48.5 2 (2) 6–120 months NS 0 0 0% Lower CN palsy, seizure, pseudo meningocele, MI CPA VS (2), Cavernous hemangioma (1), meningioma (1) NS
Prabhuraj et al. (2017)31 145 70 70 39.31 42 (28) 6 months NS 0 0 0% Morbidity: 14 (NS details) CPA VS NS
Sheikh and Kanaan (1994)35 17 12 7 26.14 1 (6) 12–109 months 0 0 0 0% 1 × persistent mild hemiparesis, 4 × tumor recurrence Cerebellum Medulloblastoma (7) NS

Abbreviations: CN, cranial nerve; CPA, cerebellopontine angle; CSF, cerebrospinal fluid; GTR, gross total resection; HCP, hydrocephalus; MI, myocardial infarction; NS, not stated; PFT, posterior fossa tumor; VS, vestibular schwannoma.

In all, 22.49% (139/618) of adult PFTs presented with preoperative hydrocephalus; 62.59% (87/139) were managed initially with a preoperative/intraoperative VPS, of which 0% were found to have postoperative hydrocephalus on CT or MR imaging, and as a result, 0% required postoperative CSF diversion management, and the resultant preoperative VPS failure rate remained 0% (0/87), indicating a complete absence of complications.

Discussion

Although PFTs in the adult population are more common than in children, studies on pre-resection CSF diversion remain limited. To the best of our knowledge, this is the first systematic review of adult PFTs undergoing pre-resection CSF diversion in the form of ETV, EVD, or ventriculoperitoneal shunting. In our systematic review, we show that the frequency of hydrocephalus in surgically managed adult PFT is 22.98% (684/2976), and persistent hydrocephalus following preoperative CSF diversion is 13.63% (78/572). Between years 1992 and 2020, we determined a pre-resection ETV failure rate of 14.66% (17/116). To manage the ETV failure rate, 82.35% (14/17) underwent VPS insertion, 11.76% (2/17) underwent a right-sided EVD, and 5.88% (1/17) underwent an ETV re-do. Between years 1986 and 2021, we determined a pre-resection EVD failure rate of 16.26% (60/369), all of which underwent VPS insertion. Finally, between years 1981 and 2013, our pre-resection VPS failure rate was 0% (0/87).

Endoscopic Third Ventriculostomy

In cases of obstructive hydrocephalus, ETV represents an alternative to permanent shunts, allowing CSF to be internally diverted to the basal cisterns and eventually be reabsorbed by arachnoid granulations. Although it is minimally invasive and avoids many implant complications associated with alternatives such as VPS and EVD, the success rate of ETV is significantly variable in the adult population.36 The ETV success score37 is a validated clinical prediction rule, allowing for the approximation of operative success in the pediatric population. Although, more recently, it has been validated in a mixed population that includes adults, there is limited application on predictive factors specific to the older population.38

Our review showed an ETV failure rate of 14.66% (17/116), requiring a second procedure in the postoperative period. ETV may fail from either an obstructive or communicating cause. In addition to CSF diversion, an EVD arguably facilitates clearance of blood clots and debris which may otherwise eventually obstruct the arachnoid granulations, potentially preventing communicating hydrocephalus in the longer term. ETV requires appropriate training to reduce the risks including injury to the basilar artery5; especially when the prepontine cistern is significantly reduced either by tumor6 or corresponding edematous mass effect from a resultant decreased space between the brainstem and clivus. A limited understanding of the anatomy and opening of the Lilliquist membrane can also exponentially increase the ETV failure rate.

Additionally, with an increased risk of intraventricular hemorrhage, there remains an increased risk of requiring permanent CSF diversion.33 Closure of the stoma is a known complication of ETV, with hypotheses including tumor spreading, scarring phenomena, and the “snow-globe effect” related to the surgical position of PFT resection.39 A lower rate of ETV efficacy correlated with prone positioning of PFT resection, in comparison to studies reporting sitting position; hypothesize that gravitational changes occurring from the prone position may contribute to stoma occlusion from blood clot deposition.39

ETV in adult PFT resection has gained popularity as a first-line therapy to treat and prevent postoperative hydrocephalus.8 Our inclusion criteria assessed ETV alone, although endoscopic treatment enables the operating surgeon to perform adjunctive procedures, such as septostomy, foraminoplasty, and aqueductoplasty, further improving intracranial hemodynamics.27 Our systematic review provides the first adult-only cohort data in the literature, but we were unable to reduce the number of ETV failure false positives due to, for example, a lack of detailed analysis of tumor entities, additional procedural factors including the opening of the Lilliquist membrane, and being unable to objectively determine the patency of the ETV on follow-up MR imaging and additional endoscopic CSF ventricular access procedures such as septostomy.

External Ventricular Drain

In a patient presenting with acute hydrocephalus, management of the associated hydrocephalus remains a critical priority. The use of an EVD, when compared to ETV and VPS insertion in the perioperative period, is the most efficient option for successful CSF diversion39 and can be performed by every grade of neurosurgeon with a low rate of complications. When compared to ETV and VPS, EVD is the only cranial CSF diversion procedure that allows for continued monitoring of CSF dynamics. However, our systematic review found a pre-resection EVD failure rate of 16.26% (60/369), all of which underwent VPS insertion. In addition to protection against postoperative hydrocephalus, perioperative EVD placement, when optimally titrated, minimizes the risk of tentorial herniation and allows a more accurate control of the amount of CSF drained.8,25,40

In our patient cohorts, due to heterogeneity within the data, we were unable to differentiate between prophylactic CSF diversion via an EVD and those requiring an EVD due to preoperative hydrocephalus. Won et al.25 assessed the need for prophylactic perioperative EVD using an Evan Ratio of >0.3, surgeon preference, and a self-developed novel grading system. The use of prophylactic EVD attracts its own risks, including upward cerebellar herniation, hemorrhage, and infection.7,8,25,41 The routine use of an antibiotic-impregnated catheter reduces the risk of infection in EVDs.42,43

Perioperative EVD placement may increase the risk of persistent hydrocephalus.44,45 Influencing factors include the duration of EVD placement, whether the EVD is on volume drainage, and the EVD setting. A correlation between the duration of EVD placement and the need for VPS has been described. A single-center retrospective study in a pediatric cohort found a mean time for EVD placement requiring definitive ventriculoperitoneal shunting of 5.8 days, compared with 4.3 days for patients not requiring a VPS.44 Most recently, an adult population single-center study assessed EVD weaning and found the rate of ventriculoperitoneal shunting requirement was higher in patients with a prolonged weaning exceeding 15 days.33 It has been reported that post-resection ETV has been effective in cases of EVD weaning failure, as an alternative to permanent shunt placement.6,8 Further prospective studies to determine the optimum parameters of EVD use, including weaning time, and use of continuous versus volume drainage in these patients to clear surgical debris, may reduce the pre-resection EVD failure rate.

Ventriculoperitoneal Shunt

Permanent shunting is commonly considered the main treatment as shunt dependency is common.11 Our systematic review found a VPS failure rate of 0% (0/87), with no patient cohort reporting a need for shunt revision or re-insertion, between 1981 and 2013. In a retrospective cohort of 123 pediatric patients with pre-resection ventriculoperitoneal shunting, there was immediate resolution of papilledema in 79% of cases, compared with 30% of those who did not have a VPS.46 The study also reported that 30.75% remained permanently shunt-free following pre-resection ventriculoperitoneal shunting.46 Few shunts require removal once placed. Although a VPS failure rate of 0% is found in the adult cohort during follow-up, the proportion of these cases that continue to have a functioning shunt in situ after tumor removal is not known. One pre-resection VPS adult patient cohort reported a morbidity rate of 20% (14/70) which did not result in a shunt revision or further CSF diversion procedure; however, the patient did not report specific morbidity details over a 6-month follow-up period.31

Although VPS cohorts showed no shunt revision pre-resection, later complications requiring later revision included shunt infection, shunt obstruction, and shunt dislocation.8 Shunt infection ranged between 1.2% and 19% and presents a clear risk of mortality.47

In the context of pre-resection VPS with a PFT, additional surgical risks and complications need to be considered, including the risk of tumor movement close to the brainstem and a possible increased risk of intratumoral hemorrhage,41,48–50 which may subsequently increase the risk of postoperative communicative hydrocephalus.33 Our VPS patient cohort reported 4 tumor recurrences,35 although not reported by this study, it may increase the risk of metastasis along shunt catheters.51,52 Unlike an EVD with the facility to regulate the amount of CSF drained, a VPS system may be associated with greater vulnerability to upward tentorial herniation.41,48–50

Although the VPS failure rate was found to be 0%, obstructive hydrocephalus may spontaneously resolve following tumor resection, indicating that in some cases nonpermanent CSF diversion in the form of an EVD or ETV may be satisfactory in patients at high risk of postoperative development of hydrocephalus.

Limitations

The conclusions of our systematic review are limited by the retrospective nature of the study and the paucity of data on pre-resection CSF drainage outcomes in adult PFT resection in comparison to pediatric studies. As a result, the sample size and lack of independent patient data were too small for robust statistical analysis.

The pre-resection ETV cohort consisted of patients between 1992 and 2020, followed by the pre-resection EVD cohort between 1986 and 2021, and finally the pre-resection VPS cohort between 1981 and 2013. Although all 3 CSF diversion groups demonstrate change in the neurosurgical management of these particular cases over the years and included patients of consecutive series, the comparison analysis was hindered by differing timelines. Additionally, endoscopy is a relatively new concept when compared to the VPS and EVD insertion skill set, with different procedures included within its scope (such as septostomy), and as a result, there is limited retrospective data.

Significantly differing and limited data on tumor characteristics, including histopathology, tumor location, size, and extent of resection, impaired our ability to compare the influence of this important variable on pre-resection CSF diversion techniques and outcomes.

Additionally, there were no standard criteria to select which patients received a pre-resection EVD, ETV, or VPS, and the choice of treatment modality was mainly based on unit and operating surgeon preference due to varying patient presentation and significant heterogeneity regarding tumor characteristics. This, however, reflects the diversity of presentation in clinical practice and thus enabled us to appreciate the difficulties encountered in decision-making.

It should also be noted that in this study we encountered limitations in the available data that precluded the measurements of additional covariates. Although we recognize the potential influence of various factors on the observed outcomes and complication rates, such as demographic characteristics, medical interventions (improvements in surgical and anesthetic techniques), and passage of time, we were unable to incorporate them into our analysis. Supplementary covariates would provide us with deeper insights regarding the efficacy of these 3 techniques. This impacts the generalizability of our findings and future explorations with more extensive data would provide a more comprehensive understanding of the role of these covariates.

Although we endeavored to define parameters for clinical hydrocephalus and radiological ventriculomegaly, the definition of hydrocephalus by other authors was not uniform. Some cohorts relied on symptoms and radiological findings,32 while others used radiological criteria alone.8 Some did not incorporate a clear definition.

We were unable to evaluate surgical positioning, long-term follow-up for individual patient data, radiological predictors such as perilesional edema or transependymal CSF outflow, and importantly, confounding factors for recurrent hydrocephalus, such as frequency of meningitis, CSF leak, and presence of pseudo-meningocele due to the paucity of data.

The lack of follow-up data limits our ability to understand the effectiveness of the CSF diversion procedures; the nature of a PFT, either malignant or benign, can itself have an impact on survival. Regardless, radiological follow-up for the tumor is a separate entity to assess the ventricular size. As a patient with a VPS is subject to further radiological investigation when admitted to the hospital when compared to a patient without one, this has the potential to bias the availability of follow-up radiological data in favor of shunt patients.

This is the first study to systematically review the role of CSF diversion procedures in adult PFTs, bringing together the evidence upon which to base treatment decisions. It enables surgeons to supplement their clinical practice with improved evidence, and to better inform preoperative discussion with their adult patients with PFTs, to reach a shared decision regarding the optimum treatment.

Conclusions

This paper is the first systematic review of adult PFT undergoing pre-resection CSF diversion in the form of ETV, EVD, or ventriculoperitoneal shunting. Ventriculoperitoneal shunting is the preoperative surgical technique that is related to the lower failure rate of postoperative hydrocephalus persistence/management. Nevertheless, the heterogeneity of the patient cohorts, reporting of the complications, short follow-up periods, and surgical expertise required for each surgical technique should be taken into consideration alongside the failure rates when a perioperative CSF diversion is considered for an adult patient presenting with this common clinical problem.

Supplementary material

Supplementary material is available online at Neuro-Oncology Practice (https://academic.oup.com/nop).

npae055_suppl_Supplementary_Materials

Acknowledgments

No portion of this paper has been previously presented or published. All coauthors have read and approved of its submission to this journal.

Contributor Information

Amisha Vastani, Department of Neurosurgery, Queens Hospital, Romford, UK.

Asfand Baig Mirza, Department of Neurosurgery, Queens Hospital, Romford, UK.

Fizza Ali, GKT School of Medical Education, King’s College London, London, UK.

Allayna Iqbal, GKT School of Medical Education, King’s College London, London, UK.

Chaitanya Sharma, GKT School of Medical Education, King’s College London, London, UK.

Abbas Khizar Khoja, GKT School of Medical Education, King’s College London, London, UK.

Babar Vaqas, Department of Neurosurgery, Queens Hospital, Romford, UK.

José Pedro Lavrador, Department of Neurosurgery, Kings College Hospital NHS Foundation Trust, Denmark Hill, UK.

Jonathan Pollock, Department of Neurosurgery, Queens Hospital, Romford, UK.

Conflict of interest statement

None declared.

Funding

No funding was received.

Authorship statement

A.V.—Writing—original draft, review and editing, formal analysis. A.B.M.—Conceptualization, methodology, data curation, writing—original draft. F.A.—Investigation, data curation. A.I.—Investigation, data curation. C.S.—Investigation, formal analysis. A.K.K.—Investigation. J.P.L., B.V., J.R.P.—Supervision and review.

Data Availability

Subject upon request.

References

  • 1. Bose A, Prasad U, Kumar A, et al. Characterizing various posterior fossa tumors in children and adults with diffusion-weighted imaging and spectroscopy. Cureus. 2023;15(5):e39144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Shih RY, Smirniotopoulos JG.. Posterior fossa tumors in adult patients. Neuroimaging Clin N Am. 2016;26(4):493–510. [DOI] [PubMed] [Google Scholar]
  • 3. Harati A, Scheufler KM, Schultheiss R, et al. Clinical features, microsurgical treatment, and outcome of vestibular schwannoma with brainstem compression. Surg Neurol Int. 2017;8(1):45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lin CT, Riva-Cambrin JK.. Management of posterior fossa tumors and hydrocephalus in children: a review. Childs Nerv Syst. 2015;31(10):1781–1789. [DOI] [PubMed] [Google Scholar]
  • 5. Marx S, Reinfelder M, Matthes M, Schroeder HWS, Baldauf J.. Frequency and treatment of hydrocephalus prior to and after posterior fossa tumor surgery in adult patients. Acta Neurochir. 2018;160(5):1063–1071. [DOI] [PubMed] [Google Scholar]
  • 6. Tamburrini G, Pettorini BL, Massimi L, Caldarelli M, Di Rocco C.. Endoscopic third ventriculostomy: the best option in the treatment of persistent hydrocephalus after posterior cranial fossa tumour removal? Childs Nerv Syst. 2008;24(12):1405–1412. [DOI] [PubMed] [Google Scholar]
  • 7. Dewan MC, Lim J, Shannon CN, Wellons JC.. The durability of endoscopic third ventriculostomy and ventriculoperitoneal shunts in children with hydrocephalus following posterior fossa tumor resection: a systematic review and time-to-failure analysis. J Neurosurg Pediatr. 2017;19(5):578–584. [DOI] [PubMed] [Google Scholar]
  • 8. Won SY, Dubinski D, Behmanesh B, et al. Management of hydrocephalus after resection of posterior fossa lesions in pediatric and adult patients—predictors for development of hydrocephalus. Neurosurg Rev. 2020;43(4):1143–1150. [DOI] [PubMed] [Google Scholar]
  • 9. Zhang C, Zhang T, Ge L, et al. Management of posterior fossa tumors in adults based on the predictors of postoperative hydrocephalus. Front Surg. 2022;9(6):886438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Sainte-Rose C, Cinalli G, Roux FE, et al. Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. J Neurosurg. 2001;95(5):791–797. [DOI] [PubMed] [Google Scholar]
  • 11. Eguiluz-Melendez A, Rodríguez-Hernández LA, López-Molina JA, et al. Obstructive hydrocephalus due to posterior fossa tumors in adults: a comparative analysis of 3 surgical techniques. World Neurosurg. 2023;175(Jul):e593–e600. [DOI] [PubMed] [Google Scholar]
  • 12. Albright L, Reigel DH.. Management of hydrocephalus secondary to posterior fossa tumors. J Neurosurg. 1977;46(1):52–55. [DOI] [PubMed] [Google Scholar]
  • 13. Di Rocco F, Jucá CE, Zerah M, Sainte-Rose C.. Endoscopic third ventriculostomy and posterior fossa tumors. World Neurosurg. 2013;79(2):S18.e15–S18.e19. [DOI] [PubMed] [Google Scholar]
  • 14. Ruggiero C, Cinalli G, Spennato P, et al. Endoscopic third ventriculostomy in the treatment of hydrocephalus in posterior fossa tumors in children. Childs Nerv Syst. 2004;20(11–12):828–833. [DOI] [PubMed] [Google Scholar]
  • 15. Ji W, Liang P, Zhou Y, et al. [Management of obstructive hydrocephalus before posterior fossa tumor resection in children]. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(11):1696–1698. [PubMed] [Google Scholar]
  • 16. Ashish S, Osaama K, Jacques M.. Surgical approaches to posterior fossa tumours. In: Kirollos R, Helmy A, Thomson S, Hutchinson P, eds. Oxford Textbook of Neurological Surgery. 1st ed. Oxford Textbooks in Surgery. Oxford, UK: Oxford University Press; 2019:375–384. [Google Scholar]
  • 17. Muthukumar N. Hydrocephalus associated with posterior fossa tumors: how to manage effectively? Neurol India. 2021;69(8):342. [DOI] [PubMed] [Google Scholar]
  • 18. Taylor WAS, Todd NV, Leighton SEJ.. CSF drainage in patients with posterior fossa tumours. Acta Neurochir. 1992;117(1–2):1–6. [DOI] [PubMed] [Google Scholar]
  • 19. Goel A. Whither preoperative shunts for posterior fossa tumours? Br J Neurosurg. 1993;7(4):395–399. [DOI] [PubMed] [Google Scholar]
  • 20. Bouras T, Sgouros S.. Complications of endoscopic third ventriculostomy: a systematic review. In: Aygok GA, Rekate HL, eds. Hydrocephalus. Vol 113. New York, NY: Springer Vienna; 2012:149–153. doi: https://doi.org/ 10.1007/978-3-7091-0923-6_30 [DOI] [PubMed] [Google Scholar]
  • 21. Waga S, Shimizu T, Shimosaka S, Tochio H.. Intratumoral hemorrhage after a ventriculoperitoneal shunting procedure. Neurosurgery. 1981;9(3):249–252. [PubMed] [Google Scholar]
  • 22. Foreman P, McClugage S, Naftel R, et al. Validation and modification of a predictive model of postresection hydrocephalus in pediatric patients with posterior fossa tumors: clinical article. J Neurosurg Pediatr. 2013;12(3):220–226. [DOI] [PubMed] [Google Scholar]
  • 23. Gopalakrishnan CV, Dhakoji A, Menon G, Nair S.. Factors predicting the need for cerebrospinal fluid diversion following posterior fossa tumor surgery in children. Pediatr Neurosurg. 2012;48(2):93–101. [DOI] [PubMed] [Google Scholar]
  • 24. Helmbold LJ, Kammler G, Regelsberger J, et al. Predictive factors associated with ventriculoperitoneal shunting after posterior fossa tumor surgery in children. Childs Nerv Syst. 2019;35(5):779–788. [DOI] [PubMed] [Google Scholar]
  • 25. Won SY, Gessler F, Dubinski D, et al. A novel grading system for the prediction of the need for cerebrospinal fluid drainage following posterior fossa tumor surgery. J Neurosurg. 2020;132(1):296–305. [DOI] [PubMed] [Google Scholar]
  • 26. Grunert P, Charalampaki P, Hopf N, Filippi R.. The role of third ventriculostomy in the management of obstructive hydrocephalus. Minim Invasive Neurosurg. 2003;46(1):16–21. [DOI] [PubMed] [Google Scholar]
  • 27. Ardakani SK, Aoude A, Ghodsi SM, Abdollahzadeh S, Khoshnevisan A.. Endoscopic third ventriculostomy in patients with vestibular schwannoma and hydrocephalus: a clinical trial. Neurosurg Q. 2014;24(4):267–271. [Google Scholar]
  • 28. Salah M, Elhuseny AY, Youssef EM.. Endoscopic third ventriculostomy for the management of hydrocephalus secondary to posterior fossa tumors: a retrospective study. Surg Neurol Int. 2022;13(5):65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Mangubat EZ, Chan M, Ruland S, Roitberg BZ.. Hydrocephalus in posterior fossa lesions: ventriculostomy and permanent shunt rates by diagnosis. Neurol Res. 2009;31(7):668–673. [DOI] [PubMed] [Google Scholar]
  • 30. Pirouzmand F, Tator CH, Rutka J.. Management of hydrocephalus associated with vestibular schwannoma and other cerebellopontine angle tumors. Neurosurgery. 2001;48(6):1246–1254. [DOI] [PubMed] [Google Scholar]
  • 31. Prabhuraj AR, Sadashiva N, Kumar S, et al. Hydrocephalus associated with large vestibular schwannoma: management options and factors predicting requirement of cerebrospinal fluid diversion after primary surgery. J Neurosci Rural Pract. 2017;08(S 01):S027–S032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Atlas MD, Perez De Tagle JRV, Cook JA, Sheehy JP, Fagan PA.. Evolution of the management of hydrocephalus associated with acoustic neuroma. Laryngoscope. 1996;106(2):204–206. [DOI] [PubMed] [Google Scholar]
  • 33. Saad H, Bray DP, McMahon JT, et al. Permanent cerebrospinal fluid diversion in adults with posterior fossa tumors: incidence and predictors. Neurosurgery. 2021;89(6):987–996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Fukuda M, Oishi M, Kawaguchi T, et al. Etiopathological factors related to hydrocephalus associated with vestibular schwannoma. Neurosurgery. 2007;61(6):1186–1193. [DOI] [PubMed] [Google Scholar]
  • 35. Sheikh BY, Kanaan IN.. Medulloblastoma in adults. J Neurosurg Sci. 1994;38(4):229–234. [PubMed] [Google Scholar]
  • 36. Tefre S, Lilja-Cyron A, Arvidsson L, et al. Endoscopic third ventriculostomy for adults with hydrocephalus: creating a prognostic model for success: protocol for a retrospective multicentre study (Nordic ETV). BMJ Open. 2022;12(1):e055570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Kulkarni AV, Drake JM, Mallucci CL, et al. Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr. 2009;155(2):254–259.e1. [DOI] [PubMed] [Google Scholar]
  • 38. Labidi M, Lavoie P, Lapointe G, et al. Predicting success of endoscopic third ventriculostomy: validation of the ETV success score in a mixed population of adult and pediatric patients. J Neurosurg. 2015;123(6):1447–1455. [DOI] [PubMed] [Google Scholar]
  • 39. Tamburrini G, Frassanito P, Bianchi F, et al. Closure of endoscopic third ventriculostomy after surgery for posterior cranial fossa tumor: the “snow globe effect”. Br J Neurosurg. 2015;29(3):386–389. [DOI] [PubMed] [Google Scholar]
  • 40. Ghani E, Zaidi GI, Nadeem M, Rehman L, Noman MA, Khaleeq-Uz-Zaman. Role of cerebrospinal fluid diversion in posterior fossa tumor surgery. J Coll Physicians Surg Pak. 2003;13(6):333–336. [PubMed] [Google Scholar]
  • 41. El-Gaidi MA, El-Nasr AHA, Eissa EM.. Infratentorial complications following preresection CSF diversion in children with posterior fossa tumors. J Neurosurg Pediatr. 2015;15(1):4–11. [DOI] [PubMed] [Google Scholar]
  • 42. Cui Z, Wang B, Zhong Z, et al. Impact of antibiotic- and silver-impregnated external ventricular drains on the risk of infections: a systematic review and meta-analysis. Am J Infect Control. 2015;43(7):e23–e32. [DOI] [PubMed] [Google Scholar]
  • 43. Mallucci CL, Jenkinson MD, Conroy EJ, et al. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation. Lancet. 2019;394(10208):1530–1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Culley DJ, Berger MS, Shaw D, Geyer R.. An analysis of factors determining the need for ventriculoperitoneal shunts after posterior fossa tumor surgery in children. Neurosurgery. 1994;34(3):402???408–402???408. [DOI] [PubMed] [Google Scholar]
  • 45. Gnanalingham KK, Lafuente J, Thompson D, Harkness W, Hayward R.. The natural history of ventriculomegaly and tonsillar herniation in children with posterior fossa tumours—an MRI study. Pediatr Neurosurg. 2003;39(5):246–253. [DOI] [PubMed] [Google Scholar]
  • 46. Raimondi AJ, Tomita T.. Hydrocephalus and infratentorial tumors: incidence, clinical picture, and treatment. J Neurosurg. 1981;55(2):174–182. [DOI] [PubMed] [Google Scholar]
  • 47. Anania P, Battaglini D, Balestrino A, et al. The role of external ventricular drainage for the management of posterior cranial fossa tumours: a systematic review. Neurosurg Rev. 2021;44(3):1243–1253. [DOI] [PubMed] [Google Scholar]
  • 48. Ostling L, Raffel C.. Editorial: complications following preresection shunting in patients with posterior fossa tumors. J Neurosurg Pediatr. 2015;15(1):1–3. [DOI] [PubMed] [Google Scholar]
  • 49. Santhanam R, Balasubramaniam A, Chandramouli BA.. Fatal intratumoral hemorrhage in posterior fossa tumors following ventriculoperitoneal shunt. J Clin Neurosci. 2009;16(1):135–137. [DOI] [PubMed] [Google Scholar]
  • 50. Zuccarello M, Dollo C, Carollo C.. Spontaneous intratumoral hemorrhage after ventriculoperitoneal shunting. Neurosurgery. 1985;16(2):245???6–245?246. [DOI] [PubMed] [Google Scholar]
  • 51. Hoffman HJ, Hendrick EB, Humphreys RP.. Metastasis via ventriculoperitoneal shunt in patients with medulloblastoma. J Neurosurg. 1976;44(5):562–566. [DOI] [PubMed] [Google Scholar]
  • 52. Kessler LA, Dugan P, Concannon JP.. Systemic metastases of medulloblastoma promoted by shunting. Surg Neurol. 1975;3(3):147–152. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

npae055_suppl_Supplementary_Materials

Data Availability Statement

Subject upon request.


Articles from Neuro-Oncology Practice are provided here courtesy of Oxford University Press

RESOURCES